ChIP Sequencing Market: Trends, Drivers, and Opportunities
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Chromatin immunoprecipitation (ChIP) Sequencing Market Projected To Reach By 2030?
The chromatin immunoprecipitation (chip) sequencing market has experienced rapid expansion recently. Projections indicate its value will increase from $15.48 billion in 2025 to $17.42 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 12.5%. Historically, this growth can be ascribed to several factors including the broadened scope of basic genomics research, increased financial support for academic research, the proliferation of next-generation sequencing platforms, a growing fascination with chromatin biology, and the establishment of more molecular biology laboratories.
The chromatin immunoprecipitation (chip) sequencing market size is projected for swift expansion in the coming years. This market is predicted to reach $29.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.6%. Key factors driving this growth during the forecast period include greater investments in epigenomics research, the increasing adoption of AI-driven genomic analysis, the expansion of precision medicine initiatives, a growing demand for multi-omics integration, and the rising utilization of cloud-based bioinformatics platforms. Significant trends anticipated in the same period involve the expanding use of genome-wide protein-DNA interaction mapping, the increasing adoption of high-throughput sequencing platforms, a rising demand for epigenetics research tools, the development of integrated bioinformatics analysis pipelines, and an elevated focus on regulatory genomics studies.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Affecting The Chromatin immunoprecipitation (ChIP) Sequencing Market Demand?
The rising incidence of prostate cancer is projected to fuel the expansion of the chromatin immunoprecipitation (ChIP) sequencing market going forward. Prostate cancer is a malignancy that forms in the prostate gland, a male organ roughly the size of a walnut that generates fluid aiding semen. In prostate cancer research, ChIP-seq provides a detailed understanding of the molecular processes driving the illness, delivering crucial insights that can lead to improved knowledge of its biology and the development of more precise and effective therapeutic approaches. For instance, according to the American Cancer Society, a US-based organization focused on cancer prevention and treatment, it was estimated in January 2023 that the US would experience 288,300 new cases of prostate cancer and 34,700 deaths from the disease in 2023. Therefore, the growing prevalence of prostate cancer is stimulating the growth of the chromatin immunoprecipitation (ChIP) sequencing market.
What Segment Categories Shape The Chromatin immunoprecipitation (ChIP) Sequencing Market Segment Landscape?
The chromatin immunoprecipitation (chip) sequencing market covered in this report is segmented –
1) By Type: DNase-Sequencing, FAIRE-Sequencing
2) By Technology: Targeted Sequencing And Re-Sequencing, Whole Genome Sequencing And Whole Exome Sequencing
3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis
4) By Application: Consumables And Reagents, Service, Other Applications
5) By End-User: Academic Research Institutes, Clinical Research Institutes, Hospitals And Clinics, Pharmaceuticals And Biotechnology Companies, Other End Users
Subsegments:
1) By DNase-Sequencing: DNase I Hypersensitivity Mapping, DNase-Seq For Open Chromatin Regions
2) By FAIRE-Sequencing: Formaldehyde-Assisted Isolation Of Regulatory Elements (FAIRE), FAIRE-Seq For Active Regulatory Regions
What Trends Are Influencing Changes In The Chromatin immunoprecipitation (ChIP) Sequencing Market?
Leading companies in the chromatin immunoprecipitation (ChIP) sequencing market are concentrating on innovative technologies, including hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing), to boost the efficiency and accuracy of epigenomic research. This strategic focus is driving advancements in drug discovery and personalized medicine. hmqChIP-seq (high-throughput multiplex quantitative Chromatin Immunoprecipitation sequencing) is an sophisticated technology designed specifically to improve the examination of epigenetic modifications across the genome. For example, in June 2024, Epigenica, a life sciences technology company from Sweden, launched its EpiFinder Platform, which integrates patented hmqChIP-seq technology. This allows for high-throughput, multiplex quantitative analysis essential for epigenomic research. This innovative platform empowers researchers to generate 192 genome-wide profiles concurrently from up to 24 samples, significantly streamlining large-scale experiments with exceptional speed and cost-efficiency.
Who Are The Companies Operating Across The Chromatin immunoprecipitation (ChIP) Sequencing Market Value Chain?
Major companies operating in the chromatin immunoprecipitation (chip) sequencing market are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc. , PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Porvair Sciences Ltd. , Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.
Get The Full Chromatin immunoprecipitation (ChIP) Sequencing Market Report:
Which Region Represents The Largest Share Of The Chromatin immunoprecipitation (ChIP) Sequencing Market?
North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Chromatin immunoprecipitation (ChIP) Sequencing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Chromatin immunoprecipitation (ChIP) Sequencing Market 2026, By The Business Research Company
Protein Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report
Dna Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Next Generation Sequencing Market 2026
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
